Ποια είναι η τιμή για Singular Genomics Systems, Inc. (OMIC)

Η τιμή για Singular Genomics Systems, Inc. (OMIC) είναι $20.01

Ποια είναι η κεφαλαιοποίηση αγοράς για Singular Genomics Systems, Inc. (OMIC)

Η κεφαλαιοποίηση αγοράς για Singular Genomics Systems, Inc. (OMIC) είναι $48.36M

Singular Genomics Systems, Inc. (OMIC) Τιμή και Κεφαλαιοποίηση Αγοράς

Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.

Η τιμή για OMIC	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$2,174,951 $48.36M	NVDA	$5.257T	+10,869,221.10%
$1,902,630 $48.36M	AAPL	$4.599T	+9,508,296.04%
$1,699,043 $48.36M	GOOG	$4.107T	+8,490,870.59%
$1,480,040 $48.36M	MSFT	$3.577T	+7,396,402.63%
$1,161,485 $48.36M	AMZN	$2.807T	+5,804,420.71%

Η τιμή για OMIC

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$2,174,951 $48.36M